Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovary.
Kaern
J
J
Department of Gynecologic Oncology, Norwegian Radium Hospital, Oslo.
Trope
C
C
Kjorstad
K E
KE
Abeler
V
V
Pettersen
E O
EO
D002288:Adenocarcinoma, Mucinous / Q000453:epidemiology / Q000235:genetics*; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D003536:Cystadenocarcinoma / Q000453:epidemiology / Q000235:genetics*; D004273:DNA, Neoplasm / Q000032:analysis*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics*; D011003:Ploidies; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis
D004273:DNA, Neoplasm